Skip to main content

Harvard Radcliffe Institute has shifted to primarily virtual operations and continues to monitor the coronavirus pandemic. See Coronavirus (COVID-19) Information and Updates.

Events & exhibitions

Making the Cut: Promises and Challenges of Gene Editing

  • Friday, October 25, 2019
  • Knafel Center
    10 Garden Street
    Cambridge, MA 02138
Group of four people seated on stage with presentation slides for "Making the Cut"
Photo by Kevin Grady

Gene editing, a technology that enables scientists to change an organism's DNA, holds promise for the prevention and cure of such complex human diseases as cancer, heart disease, and sickle cell anemia.

The techniques used, including CRISPR, have generated a great deal of excitement for their efficiency and potential impact on human health, but they have also raised legal and ethical issues regarding germline and embryo manipulation, and many countries have banned such techniques due to these concerns.

The 2019 Radcliffe Institute science symposium will bring together leading international scientists, clinicians, and ethicists to explore case studies of particular gene therapies as well as the legal and bioethical implications of this research.

#GeneEditing
#RadcliffeScience2019

Event Videos

WELCOME

Tomiko Brown-Nagin, dean, Radcliffe Institute for Advanced Study; Daniel P.S. Paul Professor of Constitutional Law, Harvard Law School; and professor of history, Harvard Faculty of Arts and Sciences


FRAMING REMARKS

Immaculata De Vivo, life sciences advisor, Radcliffe Institute for Advanced Study; professor of medicine, Harvard Medical School; and professor of epidemiology, Harvard T.H. Chan School of Public Health


SESSION 1: SCIENCE AND SOCIETY


MODERATOR

Charmaine DM Royal, associate professor of African & African American studies, biology, global health, and family medicine & community health, Duke University


SCIENCE KEYNOTE

Sylvain Moineau, Canada Research Chair in Bacteriophages, Department of Biochemistry, Microbiology, and Bio-informatics, Faculty of Science and Engineering, Université Laval (Canada)


SOCIETY KEYNOTE

Jonathan Kimmelman, James McGill Professor and director of the Biomedical Ethics Unit, Department of Social Studies of Medicine, McGill University (Canada)

SESSION 2: CASE STUDIES: HEART DISEASE; SICKLE CELL ANEMIA


MODERATOR

Omar Abudayyeh, fellow, McGovern Institute for Brain Research, MIT


SPEAKERS

Vence L. Bonham Jr., senior advisor to the director on genomics and health disparities, National Human Genome Research Institute


Kiran Musunuru, associate professor of medicine, Perelman School of Medicine, University of Pennsylvania

SESSION 3: CASE STUDIES: GENETIC ENGINEERING; DISABILITY RIGHTS


MODERATOR

Pilar N. Ossorio, professor of law and bioethics, University of Wisconsin Law School; inaugural bioethics scholar in residence, Morgridge Institute for Research


SPEAKERS

Matthew Porteus, professor of pediatrics (stem cell transplantation), Stanford University School of Medicine


Rosemarie Garland-Thomson, professor of English and bioethics in the Department of English and codirector of the Emory Disability Studies Initiative, Emory University

Group of four people seated on stage with presentation slides for

SESSION 4: CONCLUDING DISCUSSION


MODERATOR

Sharon Begley, senior writer, science and discovery, STAT


SPEAKERS

Omar Abudayyeh, fellow, McGovern Institute for Brain Research, MIT


Pilar N. Ossorio, professor of law and bioethics, University of Wisconsin Law School; inaugural bioethics scholar in residence, Morgridge Institute for Research


Charmaine DM Royal, associate professor of African & African American studies, biology, global health, and family medicine & community health, Duke University


CLOSING REMARKS

Immaculata De Vivo, life sciences advisor, Radcliffe Institute for Advanced Study; professor of medicine, Harvard Medical School; and professor of epidemiology, Harvard T.H. Chan School of Public Health

More Events & Exhibitions

01 / 02
20 Sep
2021
15 Jan
2022

Brown II

Back to top